nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA2A—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.169	0.171	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0341	0.0345	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0263	0.0266	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Other—GRM1—bone cancer	0.0261	0.0263	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—RGS1—bone cancer	0.0251	0.0254	CbGpPWpGaD
Enprofylline—PDE4A—G Protein Signaling Pathways—GNA11—bone cancer	0.0228	0.0231	CbGpPWpGaD
Enprofylline—PDE4B—G Protein Signaling Pathways—GNA11—bone cancer	0.0211	0.0213	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Other—SMO—bone cancer	0.0184	0.0186	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—RGS1—bone cancer	0.0182	0.0184	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—GRM4—bone cancer	0.0182	0.0184	CbGpPWpGaD
Enprofylline—ADORA2B—C-MYB transcription factor network—KIT—bone cancer	0.0144	0.0146	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—ATF1—bone cancer	0.013	0.0132	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—GRM4—bone cancer	0.013	0.0131	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—GNA11—bone cancer	0.0115	0.0117	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—EZH2—bone cancer	0.0115	0.0116	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—GRM1—bone cancer	0.0113	0.0114	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—GRM4—bone cancer	0.011	0.0112	CbGpPWpGaD
Enprofylline—ADORA2B—C-MYB transcription factor network—PTGS2—bone cancer	0.011	0.0111	CbGpPWpGaD
Enprofylline—Theophylline—CYP3A4—bone cancer	0.0107	1	CrCbGaD
Enprofylline—ADORA1—GPCR ligand binding—GRM1—bone cancer	0.00957	0.00967	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—GNA11—bone cancer	0.00891	0.009	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—EZH2—bone cancer	0.00887	0.00896	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GRM4—bone cancer	0.00852	0.00861	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—bone cancer	0.00812	0.00821	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—SMO—bone cancer	0.00793	0.00801	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GRM1—bone cancer	0.00739	0.00747	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GRM4—bone cancer	0.00733	0.00741	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—RGS1—bone cancer	0.00733	0.00741	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—SMO—bone cancer	0.00674	0.00681	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GRM4—bone cancer	0.00666	0.00673	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—RGS1—bone cancer	0.00666	0.00673	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GRM4—bone cancer	0.00666	0.00673	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—RGS1—bone cancer	0.00666	0.00673	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—CDK4—bone cancer	0.00648	0.00655	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GRM1—bone cancer	0.00636	0.00643	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—ATF1—bone cancer	0.00625	0.00631	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GRM4—bone cancer	0.00624	0.0063	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—RGS1—bone cancer	0.00624	0.0063	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GRM4—bone cancer	0.00616	0.00623	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—RGS1—bone cancer	0.00616	0.00623	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—RGS1—bone cancer	0.00605	0.00611	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GRM4—bone cancer	0.00605	0.00611	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GRM1—bone cancer	0.00577	0.00584	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GRM1—bone cancer	0.00577	0.00584	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GRM4—bone cancer	0.00566	0.00572	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—RGS1—bone cancer	0.00566	0.00572	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—RGS1—bone cancer	0.00559	0.00566	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GRM4—bone cancer	0.00559	0.00566	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GRM1—bone cancer	0.00541	0.00546	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GRM1—bone cancer	0.00534	0.0054	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GRM1—bone cancer	0.00524	0.0053	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—SMO—bone cancer	0.0052	0.00526	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.00508	0.00514	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—CDK4—bone cancer	0.00501	0.00506	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GRM1—bone cancer	0.00491	0.00496	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GRM1—bone cancer	0.00485	0.0049	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—RGS1—bone cancer	0.00481	0.00487	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GRM4—bone cancer	0.00481	0.00487	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.00462	0.00467	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—RGS1—bone cancer	0.00437	0.00442	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GRM4—bone cancer	0.00437	0.00442	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.00434	0.00439	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—JUN—bone cancer	0.00418	0.00422	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GRM1—bone cancer	0.00417	0.00422	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GNA11—bone cancer	0.0041	0.00414	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—SMO—bone cancer	0.00407	0.00411	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RGS1—bone cancer	0.00393	0.00398	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GRM4—bone cancer	0.00393	0.00398	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GRM1—bone cancer	0.00379	0.00383	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GNA11—bone cancer	0.00372	0.00376	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GNA11—bone cancer	0.00372	0.00376	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—IL3—bone cancer	0.00371	0.00375	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—SMO—bone cancer	0.00369	0.00373	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.00364	0.00368	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GRM4—bone cancer	0.00357	0.00361	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RGS1—bone cancer	0.00357	0.00361	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—KIT—bone cancer	0.00355	0.00359	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GNA11—bone cancer	0.00348	0.00352	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—SMO—bone cancer	0.00346	0.0035	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GNA11—bone cancer	0.00344	0.00348	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—SMO—bone cancer	0.00342	0.00345	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GRM1—bone cancer	0.00341	0.00345	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GNA11—bone cancer	0.00338	0.00342	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL3—bone cancer	0.00337	0.00341	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—IL3—bone cancer	0.00337	0.00341	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RGS1—bone cancer	0.00334	0.00338	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GRM4—bone cancer	0.00334	0.00338	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—BRAF—bone cancer	0.00334	0.00338	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GRM4—bone cancer	0.00331	0.00334	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RGS1—bone cancer	0.00331	0.00334	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—JUN—bone cancer	0.00323	0.00326	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GNA11—bone cancer	0.00316	0.0032	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—IL3—bone cancer	0.00316	0.00319	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GNA11—bone cancer	0.00313	0.00316	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—IL3—bone cancer	0.00312	0.00315	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GRM1—bone cancer	0.0031	0.00313	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL3—bone cancer	0.00306	0.0031	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GRM1—bone cancer	0.0029	0.00293	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL3—bone cancer	0.00287	0.0029	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GRM1—bone cancer	0.00287	0.0029	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL3—bone cancer	0.00283	0.00286	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—MDM2—bone cancer	0.0028	0.00283	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—TP53—bone cancer	0.00276	0.00279	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GNA11—bone cancer	0.00269	0.00272	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—SMO—bone cancer	0.00267	0.0027	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RGS1—bone cancer	0.00258	0.00261	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GRM4—bone cancer	0.00258	0.00261	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.00249	0.00251	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GNA11—bone cancer	0.00244	0.00247	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—IL3—bone cancer	0.00244	0.00246	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SMO—bone cancer	0.0024	0.00243	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GRM1—bone cancer	0.00224	0.00226	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL3—bone cancer	0.00221	0.00224	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GNA11—bone cancer	0.0022	0.00222	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SMO—bone cancer	0.00218	0.00221	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—TP53—bone cancer	0.00213	0.00215	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SMO—bone cancer	0.00204	0.00207	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ATF1—bone cancer	0.00204	0.00207	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SMO—bone cancer	0.00202	0.00204	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GNA11—bone cancer	0.002	0.00202	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL3—bone cancer	0.00199	0.00201	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—EGFR—bone cancer	0.00191	0.00193	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GNA11—bone cancer	0.00187	0.00189	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ATF1—bone cancer	0.00186	0.00188	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GNA11—bone cancer	0.00185	0.00187	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL3—bone cancer	0.00181	0.00183	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ATF1—bone cancer	0.00174	0.00176	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ATF1—bone cancer	0.00172	0.00174	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TGFBR2—bone cancer	0.0017	0.00172	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL3—bone cancer	0.00169	0.00171	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL3—bone cancer	0.00167	0.00169	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF1R—bone cancer	0.0016	0.00162	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SMO—bone cancer	0.00158	0.00159	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TGFBR2—bone cancer	0.00155	0.00156	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF1R—bone cancer	0.00146	0.00147	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TGFBR2—bone cancer	0.00145	0.00146	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GNA11—bone cancer	0.00144	0.00146	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TGFBR2—bone cancer	0.00143	0.00145	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF1R—bone cancer	0.00136	0.00138	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF1R—bone cancer	0.00135	0.00136	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ATF1—bone cancer	0.00134	0.00136	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL3—bone cancer	0.00131	0.00132	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—KIT—bone cancer	0.00116	0.00118	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	0.00112	0.00113	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—BRAF—bone cancer	0.00109	0.0011	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—EGFR—bone cancer	0.00106	0.00107	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—KIT—bone cancer	0.00106	0.00107	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF1R—bone cancer	0.00105	0.00106	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—BRAF—bone cancer	0.000993	0.001	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—KIT—bone cancer	0.000989	0.000999	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—KIT—bone cancer	0.000977	0.000988	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—EGFR—bone cancer	0.000962	0.000972	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—BRAF—bone cancer	0.000929	0.000939	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—BRAF—bone cancer	0.000918	0.000928	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MDM2—bone cancer	0.000916	0.000926	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—EGFR—bone cancer	0.000901	0.000911	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—EGFR—bone cancer	0.00089	0.0009	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MDM2—bone cancer	0.000832	0.000841	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—JUN—bone cancer	0.000796	0.000805	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MDM2—bone cancer	0.000779	0.000787	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MMP9—bone cancer	0.000774	0.000783	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MDM2—bone cancer	0.000769	0.000778	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—KIT—bone cancer	0.000763	0.000772	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—JUN—bone cancer	0.000723	0.000731	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—BRAF—bone cancer	0.000718	0.000725	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MMP9—bone cancer	0.000703	0.000711	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—EGFR—bone cancer	0.000696	0.000703	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—JUN—bone cancer	0.000677	0.000684	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—JUN—bone cancer	0.000669	0.000676	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MMP9—bone cancer	0.000659	0.000666	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MMP9—bone cancer	0.000651	0.000658	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EGFR—bone cancer	0.000626	0.000633	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MDM2—bone cancer	0.000601	0.000608	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EGFR—bone cancer	0.000568	0.000574	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EGFR—bone cancer	0.000532	0.000538	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EGFR—bone cancer	0.000526	0.000532	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TP53—bone cancer	0.000525	0.000531	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—JUN—bone cancer	0.000523	0.000528	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MMP9—bone cancer	0.000508	0.000514	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TP53—bone cancer	0.000477	0.000482	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TP53—bone cancer	0.000447	0.000452	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TP53—bone cancer	0.000442	0.000446	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EGFR—bone cancer	0.000411	0.000415	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TP53—bone cancer	0.000345	0.000349	CbGpPWpGaD
